Providing enough doses of the vaccine for Russians remains a priority, according to the researcher
Read also
MOSCOW, April 7. /TASS/. Russia’s center Vector has received many requests already for the anti-coronavirus vaccine EpiVacCorona from abroad and such messages keep pouring in, but providing enough doses of the vaccine for Russians remains a priority, the chief of Vector’s Yekaterinburg Research Institute of Viral Infections, Alexander Semyonov, said on the Vesti FM radio station on Wednesday. There have been many requests but our priority is to produce enough vaccines for the citizens of Russia and allied countries. Then we will give thought to meeting foreign requests. We have quite a few of them, he stressed.
EpiVacCorona was a second vaccine to have been certified in Russia
MOSCOW, April 7. /TASS/. The vaccine EpiVacCorona will be able to protect the vaccinated at least for one year, the chief of the Yekaterinburg Research Institute of Viral Infections (an affiliate of the center Vector), Alexander Semyonov, said on Wednesday.
Read also One year, certainly. Theoretically, its effects should last two years. For the time being we are cautious about official forecasts, because too little time has passed. The first vaccinated patients received the shots just recently, Semyonov said on the Vesti FM radio station.
Semyonov recalled that strong enough immunity against the coronavirus was generated at the end of the 42nd day after the first shot of the vaccine. Throughout the six weeks following the first vaccination wearing medical masks is obligatory. Also, the vaccinated are recommended to wash hands more often than usual and keep the social distance, because contracting the infection i
7 Apr in 15:40
Russia’s vaccine EpiVacCorona is effective against the British and South African mutations of the novel coronavirus, the chief of the Yekaterinburg Research Institute of Viral Infections Vector, Alexander Semyonov said on the Vesti FM radio station. This vaccine [EpiVacCorona] works against all strains that exist, that are known at the moment, including the British, South American and South African ones, he said.
Semyonov said should new coronavirus strains emerge, it would be possible to promptly modify the vaccines accordingly. In this respect EpiVacCorona, just like Sputnik V, is a quickly readjustable vaccine, TASS cited him as saying.
TSU and SSMU scientists are working on an herbal cancer treatment miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Medical journal confirms efficacy of Russia s EpiVacCorona vaccine plenglish.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plenglish.com Daily Mail and Mail on Sunday newspapers.